NSC

Illumina has introduced SpliceAI2, described as the next generation of tools for predicting RNA splicing patterns and transcript isoforms. The announcement targets researchers and clinical geneticists, as improved splicing prediction can help interpret genetic variants linked to rare disease and cancer. Details on performance gains and availability have not yet been widely covered beyond the company's own announcement.